Smith & Nephew (SNN) Free Cash Flow Growth (1y) (2010 - 2024)
Smith & Nephew (SNN) Free Cash Flow Growth (1y) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -1.82% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 226.77% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 9.73% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -51.69% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -109.40% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 108.16% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 133.09% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 363.84% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 29.12% |
| 10 | Smith & Nephew | 5.34 Bn | 4.77 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2.99% |
| Dec 31, 2023 | -3.47% |
| Dec 31, 2022 | -1.14% |
| Dec 31, 2021 | -6.91% |
| Dec 31, 2020 | -53.92% |
| Dec 31, 2019 | 17.58% |
| Dec 31, 2018 | -78.96% |
| Dec 31, 2017 | 113.60% |
| Dec 31, 2016 | -17.61% |
| Dec 31, 2015 | 23.94% |
| Dec 31, 2014 | 73.00% |
| Mar 31, 2014 | -0.59% |
| Dec 31, 2013 | 61.85% |
| Mar 31, 2013 | 29.01% |
| Dec 31, 2012 | 123.14% |
| Jun 30, 2012 | 348.48% |
| Mar 31, 2012 | 486.57% |
| Dec 31, 2011 | 63.51% |
| Sep 30, 2011 | -10.67% |
| Jun 30, 2011 | 153.85% |